Literature DB >> 21822666

Mechanical properties and in vivo performance of a novel sliding-lock bioabsorbable poly-p-dioxanone stent.

Qimao Feng1, Wenbo Jiang, Kun Sun, Kang Sun, Sun Chen, Lijiao Zhao, Ke Dai, Ning Ma.   

Abstract

A bioabsorbable poly-p-dioxanone (PPDO) stent with a novel sliding-lock structure was fabricated to treat stenotic peripheral vessels. The sliding-lock PPDO stents have greater radial strength (107 kPa) than PPDO stents with conventional net-tube structure (32 kPa). The sliding-lock PPDO stents were implanted into the iliac arteries of pigs, and implantation success rate was 90% indicating the feasibility of this design. Additionally, we found that sliding-lock PPDO stents kept vessels patent, although by 3 and 6 months post implantation, luminal diameter decreased slightly due to intimal hyperplasia. At 1 month post implantation, the stents were sparsely covered with endothelial cells, and by 6 months, the stents were mostly absorbed and inflammatory reaction gradually decreased as the stents were absorbed. This study shows favorable mechanical strength, degradability and efficacy for the sliding-lock PPDO stents, and supports further research and development of this unique design of polymer stents for applications in vascular devices.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21822666     DOI: 10.1007/s10856-011-4407-3

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  32 in total

1.  [Characteristic mechanical properties of balloon-expandable peripheral stent systems].

Authors:  W Schmidt; R Andresen; P Behrens; K P Schmitz
Journal:  Rofo       Date:  2002-11

2.  Negative vascular remodelling after implantation of bioabsorbable magnesium alloy stents in porcine coronary arteries: a randomised comparison with bare-metal and sirolimus-eluting stents.

Authors:  M Maeng; L O Jensen; E Falk; H R Andersen; L Thuesen
Journal:  Heart       Date:  2008-08-22       Impact factor: 5.994

3.  A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods.

Authors:  Patrick W Serruys; John A Ormiston; Yoshinobu Onuma; Evelyn Regar; Nieves Gonzalo; Hector M Garcia-Garcia; Koen Nieman; Nico Bruining; Cécile Dorange; Karine Miquel-Hébert; Susan Veldhof; Mark Webster; Leif Thuesen; Dariusz Dudek
Journal:  Lancet       Date:  2009-03-14       Impact factor: 79.321

Review 4.  Bioabsorbable coronary stents.

Authors:  John A Ormiston; Patrick W S Serruys
Journal:  Circ Cardiovasc Interv       Date:  2009-06       Impact factor: 6.546

5.  Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans.

Authors:  H Tamai; K Igaki; E Kyo; K Kosuga; A Kawashima; S Matsui; H Komori; T Tsuji; S Motohara; H Uehata
Journal:  Circulation       Date:  2000-07-25       Impact factor: 29.690

6.  Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents.

Authors:  Gaku Nakazawa; Aloke V Finn; Marc Vorpahl; Elena R Ladich; Frank D Kolodgie; Renu Virmani
Journal:  J Am Coll Cardiol       Date:  2011-01-25       Impact factor: 24.094

7.  Drug-eluting biodegradable poly-D/L-lactic acid vascular stents: an experimental pilot study.

Authors:  Ilkka Uurto; Joonas Mikkonen; Jyrki Parkkinen; Leo Keski-Nisula; Timo Nevalainen; Minna Kellomäki; Pertti Törmälä; Juha-Pekka Salenius
Journal:  J Endovasc Ther       Date:  2005-06       Impact factor: 3.487

Review 8.  Molecular basis of restenosis and novel issues of drug-eluting stents.

Authors:  Teruo Inoue; Koichi Node
Journal:  Circ J       Date:  2009-03-13       Impact factor: 2.993

9.  Studies on the efficacy and safety of polydioxanone monofilament absorbable suture.

Authors:  E Lerwick
Journal:  Surg Gynecol Obstet       Date:  1983-01

10.  Short-term effects of biocorrodible iron stents in porcine coronary arteries.

Authors:  Ron Waksman; Rajbabu Pakala; Richard Baffour; Rufus Seabron; David Hellinga; Fermin O Tio
Journal:  J Interv Cardiol       Date:  2007-12-11       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.